Flying Solo: Warfarin vs. New Oral Anticoagulants, what does the evidence say?


Subscribe on iTunes

Amol wants you to:

1. Consider how the evidence helps us decide whether to prescribe a patient warfarin or a novel oral anticoagulant for stroke prevention in atrial fibrillation.

Continuing Medical Education

Internists can receive 0.5 hours of Continuing Medical Education credit for each podcast they listen to through the Canadian Society of Internal Medicine (MOC Category 1) and the American Medical Association (PRA Category 1). To receive CME credit for listening to this podcast, please click here to fill out our Evaluation and Impact Assessment Form.

The papers

http://www.download.thelancet.com/journals/lancet/article/PIIS0140-6736(13)62343-0/fulltext 

http://www.bmj.com/content/350/bmj.h1585

http://www.bmj.com/content/350/bmj.h1857

http://www.ncbi.nlm.nih.gov/pubmed/23562920

http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)60245-8/abstract

Good Stuff

http://www.cbc.ca/radio/tapestry/good-bad-it-s-complicated-1.3120767/hearing-voices-1.3120808

Leave a Comment